Kiadis Pharma NV (XAMS:KDS) Operating Cash Flow per Share : €-0.71 (TTM As of Dec. 2020)

View and export this data going back to 2015. Start your Free Trial

What is Kiadis Pharma NV Operating Cash Flow per Share?

Kiadis Pharma NV's operating cash flow per share for the six months ended in Dec. 2020 was €-0.07. Kiadis Pharma NV's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2020 was €-0.71.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 14.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -4.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Kiadis Pharma NV's Operating Cash Flow per Share or its related term are showing as below:

XAMS:KDS' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -46.6 Med: -20 Max: 14.7
Current: 14.7

During the past 9 years, Kiadis Pharma NV's highest 3-Year average Operating Cash Flow per Share Growth Rate was 14.70% per year. The lowest was -46.60% per year. And the median was -20.00% per year.

XAMS:KDS's 3-Year OCF Growth Rate is not ranked
in the Biotechnology industry.
Industry Median: 3.5 vs XAMS:KDS: 14.70

Kiadis Pharma NV Operating Cash Flow per Share Historical Data

The historical data trend for Kiadis Pharma NV's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV Operating Cash Flow per Share Chart

Kiadis Pharma NV Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Operating Cash Flow per Share

Get a 7-Day Free Trial

-1.04

-1.06

-1.18

-1.76

-0.66

Kiadis Pharma NV Semi-Annual Data
	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20
Operating Cash Flow per Share	Get a 7-Day Free Trial											-0.62	-0.85	-0.91	-0.64	-0.07

Competitive Comparison of Kiadis Pharma NV's Operating Cash Flow per Share

For the Biotechnology subindustry, Kiadis Pharma NV's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kiadis Pharma NV's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kiadis Pharma NV's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Kiadis Pharma NV's Price-to-Operating-Cash-Flow falls into.

Kiadis Pharma NV Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Kiadis Pharma NV's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2020 is calculated as

Operating Cash Flow per Share (A: Dec. 2020 )	=	Cash Flow from Operations (A: Dec. 2020 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2020 )
	=	-24.102	/	36.615
	=	-0.66

Kiadis Pharma NV's Operating Cash Flow per Share for the quarter that ended in Dec. 2020 is calculated as

Operating Cash Flow per Share (Q: Dec. 2020 )	=	Cash Flow from Operations (Q: Dec. 2020 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2020 )
	=	-2.934	/	40.135
	=	-0.07

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2020 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.71

Kiadis Pharma NV Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Kiadis Pharma NV (XAMS:KDS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (XAMS:KDS) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP

Website

https://www.kiadis.com

Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (XAMS:KDS) Headlines

No Headlines